Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Dirschka

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
The British Journal of Dermatology|August 16, 2014
Lack of activity of betulin-based Oleogel-S10 in the treatment of actinic keratoses: a randomized, multicentre, placebo-controlled double-blind phase II trialA Pflugfelder, E Andonov, B Weide, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 16, 2019
Long-term safety and efficacy of trifarotene 50 μg/g cream, a first-in-class RAR-γ selective topical retinoid, in patients with moderate facial and truncal acneU Blume-Peytavi, J Fowler, L Kemény, et al.
The British Journal of Dermatology|February 28, 2016
A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(®) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(®) lampU Reinhold, T Dirschka, R Ostendorf, et al.
The British Journal of Dermatology|June 4, 2010
Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III studyR-M Szeimies, P Radny, M Sebastian, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 12, 2019
Somatic mutations in kinetochore gene KNSTRN are associated with basal proliferating actinic keratoses and cutaneous squamous cell carcinomaL Schmitz, B Grinblat, B Novak, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 25, 2025
KOH 5% solution versus diclofenac 3% for the treatment of actinic keratosis - Results from a three-armed RCTU Reinhold, N Leitz, R Dominicus, et al.
The British Journal of Dermatology|May 21, 2014
Clinical performance of the Nevisense system in cutaneous melanoma detection: an international, multicentre, prospective and blinded clinical trial on efficacy and safetyJ Malvehy, A Hauschild, C Curiel-Lewandrowski, et al.
The British Journal of Dermatology|February 13, 2018
A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapyC A Morton, R Dominicus, P Radny, et al.
The British Journal of Dermatology|September 14, 2011
Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placeboT Dirschka, P Radny, R Dominicus, et al.
The British Journal of Dermatology|December 21, 2012
Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosisT Dirschka, P Radny, R Dominicus, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
The British Journal of Dermatology|August 16, 2014
Lack of activity of betulin-based Oleogel-S10 in the treatment of actinic keratoses: a randomized, multicentre, placebo-controlled double-blind phase II trialA Pflugfelder, E Andonov, B Weide, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 16, 2019
Long-term safety and efficacy of trifarotene 50 μg/g cream, a first-in-class RAR-γ selective topical retinoid, in patients with moderate facial and truncal acneU Blume-Peytavi, J Fowler, L Kemény, et al.
The British Journal of Dermatology|February 28, 2016
A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(®) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(®) lampU Reinhold, T Dirschka, R Ostendorf, et al.
The British Journal of Dermatology|June 4, 2010
Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III studyR-M Szeimies, P Radny, M Sebastian, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 12, 2019
Somatic mutations in kinetochore gene KNSTRN are associated with basal proliferating actinic keratoses and cutaneous squamous cell carcinomaL Schmitz, B Grinblat, B Novak, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 25, 2025
KOH 5% solution versus diclofenac 3% for the treatment of actinic keratosis - Results from a three-armed RCTU Reinhold, N Leitz, R Dominicus, et al.
The British Journal of Dermatology|May 21, 2014
Clinical performance of the Nevisense system in cutaneous melanoma detection: an international, multicentre, prospective and blinded clinical trial on efficacy and safetyJ Malvehy, A Hauschild, C Curiel-Lewandrowski, et al.
The British Journal of Dermatology|February 13, 2018
A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapyC A Morton, R Dominicus, P Radny, et al.
The British Journal of Dermatology|September 14, 2011
Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placeboT Dirschka, P Radny, R Dominicus, et al.
The British Journal of Dermatology|December 21, 2012
Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosisT Dirschka, P Radny, R Dominicus, et al.
Pageof 6